BSEOthers2d ago · 27 Jul 2026, 09:23 pm

Annual Report for the financial year 2025-26

Entero Healthcare Solutions Ltd · 544122

✦ AI SummaryResults

Entero Healthcare Solutions Ltd has announced its Annual Report for the financial year 2025-26, along with the Notice convening the 8th Annual General Meeting (AGM). The report highlights the company's performance, financial statements, and corporate governance report. The AGM will be held on August 19, 2026, through video conferencing.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Entero Healthcare Solutions Ltd - 544122 - Reg. 34 (1) Annual Report.

Attachments (1)

📄

63ca4e76-520d-4057-bfec-9769100d17ce.pdf

pdf

Download →
View document text
Ref: 21/SE/LC/2026-27 Date: July 27, 2026 Scrip Code BSE: 544122 NSE: ENTERO ISIN: INE010601016 Head, Listing Compliance Department Head, Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, Plot No. C/1. G Block, Mumbai - 400001 Bandra -Kurla Complex, Bandra (East), Mumbai- 400051 Dear Sir/Madam, Subject: Annual Report for the financial year 2025-26 along with the Notice convening the 8th Annual General Meeting (“AGM”) This is further to our intimation letter dated May 25, 2026, bearing reference number 06/SE/LC/2026-27, we hereby inform you that 8th AGM of the Members of Entero Healthcare Solutions Limited (“the Company”) will be held on Wednesday, August 19, 2026, at 12:30 p.m. (IST) through Video Conferencing (VC)/Other Audio - Visual Means (OAVM), in compliance with the applicable circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India. Pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Annual Report of the Company for the financial year 2025-26 along with the AGM Notice. The Annual Report and AGM Notice are dispatched through electronic mode to all Members whose e-mail addresses are registered with the Company/Registrar and Share Transfer Agent/Depository Participant(s). Further, pursuant to Regulation 36 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has dispatched a letter to the Members whose e-mail addresses are not registered with the Company/ Registrar & Share Transfer Agent/Depository Participant(s), providing a web-link for accessing the Annual Report and AGM Notice as available on the Company's website at Entero Details of the 8th Annual General Meeting: Particulars Details Date and Time of 8th AGM Wednesday, August 19, 2026, at 12:30 p.m. Venue / Mode Video Conferencing / Other Audio & Visual Means Cut-off date Wednesday, August 12, 2026 Commencement of E-Voting Sunday, August 16, 2026, at 9:00 a.m. (IST) End of E-Voting Tuesday, August 18, 2026, at 5:00 p.m. (IST) The above information is also made available on the website of the Company at www.enterohealthcare.com This is for your information and records. Yours faithfully, For Entero Healthcare Solutions Limited Sanu Kapoor Vice president- Group General Counsel, Company Secretary & Compliance Officer Encl: as above NNEEXXTT IISS NNOOWW EEXXPPAANNDDIINNGG HHOORRIIZZOONNSS I NIN HHEEAALLTTHHCCAARREE AANNNNUUAALL RREEPPOORRTT 22002255--2266 TABLE OF CORPORATE OVERVIEW CONTENTS 01 Theme Introduction 02 Entero At a Glance PG. 01-28 18 Board of Directors 19 Chairman's Message 20 MD & CEO's Message 22 Entero's Philosophy 23 Entero’s Value Proposition 24 CSR Activity 26 Performance Highlights 27 Operational Highlights 28 Corporate Information STATUTORY REPORTS 29 Management Discussion and A nalysis Entero House 35 Board’s Report PG. 29-98 58 Corporate Governance R eport 76 Business Responsibility and Sustainability Report 03 FINANCIAL STATEMENTS 99 Standalone Financial S tatements 171 Consolidated Financial S tatements PG. 99-247 NOTICE OF AGM PG. 250-270 To download or to read this report online, please log on to https://www.enterohealthcare.com/ NEXT IS NOW Building the Healthcare Platform EXPANDING HORIZONS IN of Tomorrow, with HEALTHCARE Scale, Speed & Intelligence, Today. The future of healthcare is being shaped by speed, At its core, Entero embodies a belief that meaningful progress connectivity and the ability to respond to evolving patient is driven by the courage to anticipate change and the needs with greater precision and purpose. Across the commitment to lead it. As healthcare continues to evolve, the healthcare ecosystem, boundaries are being redened as journey ahead will belong to those who are ready to shape the technology, access and innovation come together to create future with vision, purpose and responsibility. more integrated and efficient models of care. In this changing landscape, progress belongs to organizations that are prepared to think ahead, adapt faster and build with a long- term vision. “Next is Now” reects a mindset of continuous evolution — one that embraces transformation not as a future aspiration, but as a present-day responsibility. It represents the pursuit of broader possibilities across healthcare delivery, supply chains, patient engagement and digital enablement. As the industry moves toward smarter, more connected ecosystems, the focus is shifting from scale alone to sustainable impact, agility and resilience. Expanding horizons in healthcare also means strengthening collaboration across stakeholders, unlocking new opportunities for innovation and enabling seamless access to healthcare solutions. It is about creating ecosystems that are more responsive, transparent and future-ready, while remaining anchored in trust and reliability. ANNUAL REPORT 2025-26 ENTERO AT A GLANCE STRENGTHENING THE CORE, EXPANDING THE REACH Entero Healthcare Solutions is building one of India’s most FY26 marked a signicant milestone in Entero’s evolution. The comprehensive and integrated healthcare distribution Company delivered ₹6,591 crore in revenue, representing platforms, connecting healthcare manufacturers, pharmacies, 29.3% reported growth and 31.5% like-for-like growth, hospitals, and healthcare providers through a technology- substantially outperforming the Indian Pharmaceutical enabled nationwide network. Market (IPM). Organic growth remained strong at 15.6%, enabling Entero to consistently gain market share while Operating in a healthcare supply chain industry valued at over maintaining disciplined execution. USD 33 billion, Entero addresses one of the largest and most fragmented opportunities within India’s healthcare The Company’s platform today serves 105,300+ Retail ecosystem. By combining scale, technology, operational Pharmacy Customers, 3,600+ Hospital Customers, 523 excellence, and strategic acquisitions, the Company is creating Districts Covered, 136 Warehouses, 97,500+ SKUs Handled and a platform designed to improve accessibility, efficiency, and 3,300+ Manufacturer Relationships. This extensive network reliability across the healthcare value chain. enables timely product availability, efficient inventory 02 NEXT IS NOW EXPANDING HORIZONS IN HEALTHCARE CORPORATE STATUTORY FINANCIAL NOTICE FOR OVERVIEW REPORTS STATEMENTS AGM management, and deep market penetration across urban, rapidly growing MedTech segment. Through a combination of semi-urban, and emerging healthcare markets. organic initiatives and strategic acquisitions, the Company established meaningful scale across diagnostics, medical A dening development during FY26 was Entero’s expansion devices, cardiology, orthopaedics, consumables, and imaging- beyond traditional pharmaceutical distribution into the related products. Entero is transforming scale into sustainable growth, protability, & healthcare access across India. 6.29 Lakh + Sq. Ft in 50 CITIES End to End cold chain INFRASTRUCTURE COMPLIANT The MedTech business is expected to contribute more than Operational discipline and working capital optimization ₹1,000 crore of annualized revenue in FY27, signicantly enabled Entero to achieve ₹96 crore in operating cash ow, a expanding Entero’s addressable market while strengthening signicant milestone in the Company’s growth journey. Net its margin prole and long-term growth prospects. working capital improved to 59 days by Q4 FY26, while return metrics strengthened meaningfully, with ROCE increasing to Technology remains central to Entero’s operating model. 14.6% and ROE improving to 12.5%. Proprietary digital platforms enable real-time inventory visibility, intelligent procurement, demand forecasting, As healthcare distribution continues to consolidate and warehouse optimization, and data-driven decision making. formalize, Entero is uni [Showing first 8,000 characters — download PDF for full document]